Your browser is: WebKit 537.36. This browser is out of date so some features on this site might break. Try a different browser or update this browser. Learn more.✕

Naomi Kresge

Senior Reporter

Sleep in Midnight Sun Means Sticking to Your Internal Clock

Prognosis

Sleep in Midnight Sun Means Sticking to Your Internal Clock

Novo To Sell Weight-Loss Drug Wegovy Directly To Patients

Health

WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price

Inside Novo Nordisk A/S "Factory Of The Future"

Health

Novo Seeks Deals to Reverse Slide in Weight-Loss Market It Made

Hims’ Super Bowl Ad Hit For ‘Misleading’ Weight-Loss Claims

Health

Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs

The Weight-Loss Drug Frenzy Is Outrunning The Company Novo Nordisk A/S Behind It

Health

Novo Nordisk Obesity Shot Tied to Greater Weight Loss at Lower Doses

DENMARK-PHARMACEUTICAL-NOVONORDISK-EARNINGS-OBESITY

Health

Novo’s Latest Obesity Drug Shows 24% Weight Loss in Small Trial

Eli Lilly & Co. signage on the floor of the New York Stock Exchange.

Eli Lilly to Buy Gene-Editing Biotech Verve for $1.3 Billion

Two overweight women walk at the 61st Mo

Prognosis

Body Scan Makers Are Trying to Cash in on Obesity Drug Boom

Second Teenage Boy Dies From Liver Failure After Sarepta Gene Therapy Treatment

Health

Second Teenage Boy Dies From Liver Failure After Sarepta Gene Therapy Treatment

BioNTech

Health

BioNTech to Buy CureVac for $1.25 Billion for Cancer Boost

BioNTech in Marburg, Germany

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Wegovy Effect: A Weight Loss Wonder Drug's Impact on Denmark's Economy

The Obesity-Drug Battle Is Heating Up After Novo's CEO Ouster

The Wegovy maker’s executive shift is a sign of just how much it has fallen behind rival Lilly and its Zepbound shot.

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen Interview

Health

Novo CEO Was Blindsided on Call by Chairman Before His Departure

Lars Fruergaard Jorgensen

Novo Replaces CEO Jorgensen After Lilly Rivalry Hits Shares

Pharmacies To Vote On Work To Rule In Face Of Dwinding Financial Support From Government

Health

Trump’s US Drug-Pricing Plan Would Cost the Rest of the World

Inside Novo Nordisk A/S "Factory Of The Future"

Health

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

Weight-Loss Drug Zepbound As Patients Face Shortages

Health

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

Novo To Sell Weight-Loss Drug Wegovy Directly To Patients

Health

Novo Nordisk Gains as CFO Touts Wegovy’s Rebound Potential

Novartis AG signage on the floor of the New York Stock Exchange.

Health

Novartis to Buy Regulus Therapeutics for as Much as $1.7 Billion

Europe Office Demand Rises on Boost From Banks and Insurers

Health

Novartis Lifts Outlook on Growth in Cancer, Psoriasis Drugs